The goal of this clinical trial is to evaluate the effectiveness of the mHealth survivorship program in enhancing health-related quality of life among colorectal cancer survivors. It is hypothesized that participants receiving the mHealth-based survivorship program will report significantly higher levels of health-related quality of life and a lower level of distress, depression, anxiety, fatigue, and bowel dysfunction compared to those in the control group.
Participants in the intervention group will:
Use the survivorship programme through mHealth every day for 3 months Be called by the healthcare provider every 2 weeks for consultation
Participants in the control group will receive the usual care
be 18 or older (1);
Vietnamese-speaking CRC patients who have completed active treatment and are preparing for discharge (2);
provide consent and complete questionnaires independently (3);
no metastatic and second cancers (4);
mental health diseases;
receiving anxiety or depression treatment or cognitive/learning problems.